Deep vein thrombosis thrombectomy device with embolic protection

ChangeBridge: Patent Grants - Diagnosis & Surgery (A61B)

Published March 31st, 2026

Detected April 1st, 2026

Summary

USPTO granted patent US12588925B2 to Acotec Technologies Limited for a thrombectomy device designed to treat deep vein thrombosis. The device features a coring member to disintegrate blood clots from the proximal side and a catch member anchored on the distal side to prevent embolization. The patent covers 46 claims and is classified under multiple A61B medical device categories.

View original document View source feed page

What changed

The USPTO issued Patent No. US12588925B2 to Acotec Technologies Limited on March 31, 2026, granting exclusive rights to a thrombectomy system combining mechanical thrombus fragmentation with embolic protection. The invention includes independent coring and catch members for staged clot removal, with applications in A61B 17/3207 and related classifications covering 46 total claims.

Patent holders may now commercialize the protected technology; no immediate action is required by healthcare providers or manufacturers. This grant represents standard intellectual property administration with no compliance obligations or deadlines. Parties interested in licensing or designing around this patent should consult the full claims and CPC classifications listed.

Source document (simplified)

← USPTO Patent Grants

Deep vein thrombosis thrombectomy device with embolic protection

Grant US12588925B2 Kind: B2 Mar 31, 2026

Assignee

Acotec Technologies Limited

Inventors

Alan Thomas, Jon Schabert, Michael Thai, Tao Nguyen

Abstract

A thrombectomy device includes a coring member configured to disintegrate a thrombus in a vessel into fragments from a proximal side of the thrombus and a catch member configured to be anchored at a distal side of the thrombus to provide embolic protection. The coring member and the catch member are operable independently of each other. Methods of removing a thrombus from a vessel employ a rotating coring device to disintegrate the thrombus into fragments.